Effect of sustained-release metronidazole in peri-implantitis treatment

Phase 2

Recruiting

• Conditions: Peri-implantitis.; Other endosseous dental implant failure; M27.69

• Registration Number: IRCT20211103052960N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Presence of pre-implant disease
No history of pre-implant surgery treatment
pocket depth>6 mm
Positive bleeding on probing
No antibiotics and mouthwash and periodontal treatment in the last 6 weeks
Absence of underlying disease
PFM Base Restoration

Exclusion Criteria

Pregnancy and breastfeeding
Allergy to metronidazole
Chronic drug use

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence or absence of plaque on tooth and implant surfaces (mesial, distal, buccal and lingual surfaces). Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;The distance between the gingival margin and the depth of the envelope is in millimeters. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;Presence or absence of bleeding after probing. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;The distance between the acrylic stent and the depth of the pocket. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.